⌘K
Loading ticker…
As of 2026-08-24, Emerson Electric Co. (EMR) has a 3-month relative strength percentile of 75 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47.8 (Neutral). Sector: Technology, ranked 2 of 11. Average daily range 2.7%, relative volume 0.58×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
EMR is in a stage 2 uptrend, week 4. Currently in a 9-day base; basing ADR 2.0% (broad 2.8%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 6.3% / 11.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
EMR is held by 73 ETFs as of May 2026. Top owner: PAVE at 2.64% weight, $357M notional. Top 3 carry $614M.
Held by 268 ETFs · $11.7B across latest filings · largest weight 5.52% (MAKX).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PAVEGlobal X U.S. Infrastructure Development ETF | 2.64% | $357M | −0.18 pp |
| NOBLProShares S&P 500 Dividend Aristocrats ETF | 1.46% | $161M | +0.06 pp |
| VISVanguard Industrials ETF | 1.15% | $96M | −0.05 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.12% | $86M | −0.02 pp |
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.24% |
| $52M |
| −0.02 pp |
| MGV | 0.39% | $49M | −0.03 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.11% | $48M | −0.02 pp |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.26% | $41M | −0.02 pp |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.14% | $36M | −0.02 pp |
| NUKZ | 2.47% | $22M | −0.08 pp |
Showing 10 of 73 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EMR Jan avg: 0.94% median: -0.45% win: 50% σ: 8.27% n: 4 2022-04-12 → 2026-07-31 | EMR Feb avg: 1.08% median: -1.92% win: 50% σ: 11.32% n: 4 2022-04-12 → 2026-07-31 | EMR Mar avg: -2.86% median: -2.24% win: 50% σ: 10.03% n: 4 2022-04-12 → 2026-07-31 | EMR Apr avg: -1.92% median: -4.13% win: 20% σ: 5.13% n: 5 2022-04-12 → 2026-07-31 | EMR May avg: 2.33% median: 2.41% win: 60% σ: 7.54% n: 5 2022-04-12 → 2026-07-31 | EMR Jun avg: 3.10% median: -0.47% win: 40% σ: 10.79% n: 5 2022-04-12 → 2026-07-31 | EMR Jul avg: 6.88% median: 6.31% win: 100% σ: 4.60% n: 5 2022-04-12 → 2026-07-31 | EMR Aug avg: -5.25% median: -9.27% win: 25% σ: 8.54% n: 4 2022-04-12 → 2026-07-31 (current) | EMR Sep avg: -2.24% median: -1.17% win: 25% σ: 5.95% n: 4 2022-04-12 → 2026-07-31 | EMR Oct avg: 3.95% median: 2.70% win: 50% σ: 11.19% n: 4 2022-04-12 → 2026-07-31 | EMR Nov avg: 7.14% median: 5.25% win: 50% σ: 12.01% n: 4 2022-04-12 → 2026-07-31 | EMR Dec avg: 0.69% median: -0.10% win: 50% σ: 6.61% n: 4 2022-04-12 → 2026-07-31 |